XTL BIOPHARMACEUTICALS LTD. Adjustments For Decrease Increase In Other Operating Receivables
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Adjustments For Decrease Increase In Other Operating Receivables of $25.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-22.
Discontinued › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables · last filed 2023-03-22
| Period end | Adjustments For Decrease Increase In Other Operating Receivables 12 month |
|---|---|
| 2022-12-31 | $25.00K 20-F · filed 2023-03-22 |
| 2021-12-31 | -$31.00K 20-F · filed 2023-03-22 |
| 2020-12-31 | $23.00K 20-F · filed 2023-03-22 |
| 2019-12-31 | -$29.00K 20-F · filed 2022-03-30 |
| 2018-12-31 | $39.00K 20-F/A · filed 2021-05-19 |
| 2017-12-31 | $209.00K 20-F · filed 2020-03-12 |
| 2016-12-31 | -$114.00K 20-F · filed 2019-03-11 |
| 2015-12-31 | $36.00K 20-F · filed 2018-03-15 |